Quick Answer
Lunai Bioworks Inc. reported Cash and Equivalents of $92.7 thousand for fiscal year 2025.
Lunai Bioworks Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $92.7K | -58.0% |
| 2024 | $220.5K | -88.2% |
| 2023 | $1.87M | -79.6% |
| 2022 | $9.17M | -55.6% |
| 2021 | $20.66M | +137.6% |
| 2020 | $8.70M | -29.2% |
| 2019 | $12.28M | -21.3% |
| 2018 | $15.60M | +295.8% |
| 2017 | $3.94M | +16768.0% |
| 2016 | $23.4K | -84.5% |
| 2016 | $151.2K | -64.1% |
| 2015 | $421.1K | -86.0% |
| 2014 | $3.01M | +15909.5% |
| 2013 | $18.8K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $491.6K | +57.7% | -21.3% |
| September 30, 2025 | $624.8K | +183.3% | +574.0% |
| June 30, 2025 | $92.7K | -58.0% | -90.0% |
| March 31, 2025 | $923.0K | +195.2% | +196.1% |
| December 31, 2024 | $311.8K | +27.8% | +41.3% |
| September 30, 2024 | $220.6K | -57.9% | +0.0% |
| June 30, 2024 | $220.5K | -88.2% | -29.5% |
| March 31, 2024 | $312.7K | -89.4% | +28.2% |
- Lunai Bioworks Inc. showed a decrease of -58.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2013–2025 period, Lunai Bioworks Inc.’s cash and equivalents has grown by 393.2% (from $18.8 thousand to $92.7 thousand).
- The most recent figure is from Lunai Bioworks Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: